Sports Technology and Athlete Data Toolkit: Consent, Wearables, League Rules, and Commercial Rights

By Casey Scott McKay · 2024-12-30

A professional athlete is measured continuously by devices they did not choose, under terms they did not negotiate, by an employer whose decisions about them are worth millions and are made without explanation. This toolkit assembles the working material for practitioners advising clubs, leagues, sports technology vendors, and athletes. It covers the collective bargaining provisions that are the operative law in unionised sport, and the separation between clinical and performance records on which every other control depends. It sets out the genetic information prohibition that is a prohibition rather than a risk, and the biometric statutes whose largest financial exposure sits at the stadium gate rather than on the training pitch. It works through device approval and consent, the vendor data grants that routinely exceed what a club can lawfully give, and the benchmarking thresholds that make aggregation defensible. It closes with official data and prop market supply, likeness and digital replicas, the populations without collective protection, incident response, and clause language.

IP and Technology > Privacy Data Security | Toolkit | Published 30 December 2024 - Updated 4 January 2026 | Casey Scott McKay - marksy.us

Summary. An athlete is measured continuously by devices they did not choose under terms they did not negotiate. This toolkit covers the collective bargaining provisions that govern in unionised sport, the clinical and performance separation, the genetic prohibition, biometric compliance at the venue, device approval and consent, vendor grants and benchmarking thresholds, official data and prop market supply, likeness and digital replicas, the populations without collective protection, and incident response.

Keywords: athlete data · collective agreements · approved devices · wearable consent · medical separation · genetic prohibition · biometric release · vendor grants · benchmarking thresholds · official data · prop markets · name image likeness · digital replicas · youth athletes · breach notification · league rules

Start Here

One test governs everything below, and it is worth stating first: would this arrangement survive being described accurately to the athlete being measured? Not in the consent form — out loud, in a sentence, to the person whose body generates the data.

Four structural facts follow from that.

The operative law is a collective bargaining agreement. Monitoring is a term and condition of employment and therefore a mandatory subject of bargaining under 29 U.S.C. § 158, and the major sports have negotiated in detail what may be collected, by whom, using which devices, for what purposes, with what access controls, and on what commercial terms. A club that complies with a privacy statute and breaches the collective agreement has a grievance.

The inference is more sensitive than the record. Composite readiness scores built from heart rate variability and sleep are health information whatever the dashboard calls them, and injury-prediction outputs are statements about an individual's future health used to inform employment decisions.

The largest financial exposure is at the turnstile. Biometric statutes with written-release requirements and statutory damages bite hardest on stadium entry systems, and the affected population is spectators rather than athletes.

And the vendor's standard grant is the most likely single breach of obligations a club intended to honour, because it claims perpetual rights for product improvement and benchmarking that the collective agreement does not permit the club to give.

See Every Step Recorded for the doctrinal treatment, Advising a Sports Technology Business or Team for the sequence, and the Athlete Data Checklist for the working list.

Part one: the collective agreement and the data inventory

Read the data provisions in full rather than relying on a summary, and record: what may be collected and by which devices; whether participation is voluntary and what anti-retaliation protection applies; the permitted purposes as a closed list; whether use in contract negotiation, arbitration, or discipline is prohibited; the permitted access list within the club; the athlete's own access right; portability on transfer; retention and deletion on departure; the commercialisation provisions including consent and revenue share; the joint committee's remit and device approval process; and the grievance procedure.

Then build the inventory. Positional tracking with its sampling rate; inertial and load measurement; cardiac monitoring including variability and recovery indices; sleep and recovery monitoring with the collection location recorded; metabolic and biochemical testing; neurocognitive assessment; identification biometrics at facilities and venue; video and any computer vision derivation from it; and any stream collected by a device the athlete owns personally.

For each stream record the source system and vendor, the resolution, the storage location, the retention as configured rather than as documented, the access list as configured in the system, every onward flow, cross-border transfers and their mechanism, and the collective agreement provision permitting it. Flag every stream with no identifiable basis and stop it.

Record what each stream reveals at its actual resolution rather than what it is called, and assess re-identification honestly on any dataset described as anonymised — a longitudinal physiological profile with position, age, and load characteristics is close to identifying within a few hundred professionals.

And produce the inventory as a document that could be shown to a union, because at some point it will have to be.

Part two: medical separation, genetics, and biometrics

Separate the clinical from the performance record technically, not procedurally. Hold the medical record under clinical control, accessible to treating clinicians and the athlete; hold the performance record separately without clinical content; and write a protocol stating what crosses the boundary — availability status yes, diagnosis no — and who decides.

Document the clinician's dual role rather than leaving it ambiguous, because the same physician frequently treats the athlete and reports to the club as employer.

Apply the employment constraints. 42 U.S.C. § 12112 limits medical examinations and inquiries and requires medical information to be maintained as a confidential record separate from personnel files, which is not satisfied by a different drawer of the same cabinet.

Treat the genetic prohibition as absolute. 42 U.S.C. § 2000ff prohibits an employer from requesting, requiring, or purchasing genetic information, including family medical history, and from discriminating on that basis. Build a firewall rather than a risk assessment, and close the leak routes: athletes volunteering consumer test results; clinician-ordered tests whose findings reach performance staff; vendor products incorporating genetic markers; and academies in permissive jurisdictions.

Govern injury and health prediction. Identify every analytic producing a forecast about an individual's future health, who sees the output, what decisions it informs, and whether the athlete can see and challenge it — because a prediction informing selection, renewal, or compensation raises a discrimination question before it raises a privacy one.

Then the biometric layer. Identify every collection point of a statutory identifier: facility access, stadium entry, ticketing, payment, and identification cameras. Provide written notice of the fact of collection, the purpose, and the retention period; obtain a written release before collection; publish a retention and destruction schedule; prohibit sale; and flow every obligation to the technology vendor.

Provide a non-biometric alternative lane, and quantify the exposure by collection point and volume, noting that Rosenbach v. Six Flags Entertainment Corp. holds a technical violation sufficient for standing.

Analyse per system rather than per programme, since a positional coordinate stream probably is not a statutory identifier and a facial geometry template plainly is. See Your Face as Data and the Biometric Data Checklist.

And route agent and insurer requests through the clinician, logging each one.

Part three: devices, consent, and vendor grants

Confirm every deployed device is on the approved list, that the joint committee approved the specific model, and that approval of a device has not been treated as approval of every use of its output. Submit new technologies before deployment, not after.

Draft the athlete consent as one readable page: what is collected, at what resolution, where, by whom, for what purposes, who can see it, retention, and how to withdraw. State the anti-retaliation position explicitly. Treat home collection under a separate consent with tighter limits, and address capture of family members by home sensors.

Test withdrawal honestly. If collection stops but existing data stays, derived models retain it, and the aggregate is unaffected, then say so — a consent that cannot practically be withdrawn is a formality and should be described as one.

Version and record consent, and refresh it when new technology is introduced mid-contract.

Then read the vendor's data grant before anything else in the agreement. The standard position claims a perpetual, irrevocable licence for product improvement, research, benchmarking, and model development, surviving termination — and the club cannot grant rights it does not hold, so a grant exceeding the collective agreement is a breach rather than a transfer.

Negotiate benchmarking specifically, because it is the vendor's real commercial interest and every club wants the resulting league norms. Define a minimum cohort size; prohibit outputs attributable to an individual or a single club; require a documented aggregation methodology; reserve an audit right; and require notice before publication.

Address model ownership expressly: who owns models trained on the club's data, whether they may serve other customers, whether the club receives a licence, and what happens on termination.

Control sub-processing, impose security as specific controls with breach notification in hours, and require the vendor to support athlete access requests, deletion on departure, and record production for grievances.

And draft the exit at signature — machine-readable export, defined timescale, deletion with certification including backups, and the treatment of derived models — because there is no leverage at termination. See the Data Licensing Checklist.

Part four: the commercial layer

Understand what is not owned. Facts about a sporting event are not property — Feist Publications, Inc. v. Rural Telephone Service Co. — and National Basketball Ass'n v. Motorola, Inc. applied that to real-time sports data, leaving only a narrow hot news residue.

Build the moat where it exists: venue access control, accreditation and ticket terms, control of the capture technology, exclusive supply contracts, and — in betting markets that require it — statutory official data mandates, which convert a speed advantage into a legal one and are the sector's most consequential regulatory feature.

Structure the official data supply with latency and accuracy commitments, audit rights, sub-licensing limits, territory, bet-type scope, and integrity monitoring obligations.

Address player prop markets specifically, since they monetise an individual athlete using data generated by their body. Confirm the collective agreement position and the consent position before agreeing supply, and expect this to be the sharpest negotiation of the next bargaining rounds.

Keep tracking-derived market supply separate from event data, because purpose limitations restricting wearable data to health and performance purposes do not permit settling a market on sprint speed.

Handle broadcast enhancement licensing with attention to what the underlying consent permits, since the graphics layer is built from the same tracking stream.

Clear likeness separately from data rights in games, fantasy, advertising, trading cards, and merchandise. Realistic depiction in a game is not protected by a First Amendment defence following Keller v. Electronic Arts Inc. and Hart v. Electronic Arts, Inc., and Zacchini v. Scripps-Howard Broadcasting Co. remains the Supreme Court's only treatment of performance appropriation. Screen for false endorsement under 15 U.S.C. § 1125 and check the state law position for each athlete's domicile. See Clearing and Licensing Name, Image, and Likeness and the Name, Image, and Likeness Clearance Checklist.

Address digital replicas expressly in every new agreement: whether synthesis is permitted, for which purposes, with per-use approval or a defined scope, for what term, at what compensation, and after death. Do not rely on "all media now known or hereafter devised" to cover it — say it or do not do it. See Rights That Outlive You.

Protect the analytics as trade secret under 18 U.S.C. § 1836 with reasonable measures per Rockwell Graphic Systems, Inc. v. DEV Industries, Inc..

Address unauthorised collection through venue and accreditation terms, noting the limits of 18 U.S.C. § 1030 after Van Buren v. United States and hiQ Labs, Inc. v. LinkedIn Corp..

And ensure revenue share calculations match the collective agreement and can be evidenced.

Part five: the populations without collective protection

College athletes are instrumented with the same technology and have no collective agreement. Educational records rules may cover some of the data, producing the odd result of a transcript framework applied to heart rate variability, and whether performance data falls within an athlete's name, image, and likeness rights is unsettled. Advise institutions to adopt professional-standard protections voluntarily rather than litigating the question, and keep the consent separate from the scholarship agreement.

Academy and youth athletes are minors. Parental consent in the required form, children's privacy rules where collection is through an online service, a materially shorter retention period, deletion on departure by default, and no genetic or predictive profiling. The record created at twelve should not follow the athlete for life.

Non-unionised professional sport relies on individual negotiation, and the standard contract is a starting position rather than market practice. The achievable improvements, in order of value: access to one's own data; portability on departure; a prohibition on use in contract or arbitration proceedings; deletion of physiological data on departure; consent to commercial licensing; a revenue share; and synthesis control.

International and Olympic athletes add anti-doping obligations — whereabouts data, sample records, therapeutic use exemptions — flowing between testing authorities, international federations, national bodies, and event organisers across jurisdictions, with transfer mechanisms frequently unidentified.

Officials, coaching staff, matchday staff, and trial participants are measured too and are almost never covered by the athlete framework.

And spectators are the largest measured population at any venue and the group most likely to produce a statutory class action.

Clause bank

Athlete consent — core provisions. We record the following while you train and play: where you are on the pitch, about ninety times a minute; how hard you accelerate and decelerate; your heart rate; and, if you agree separately, how you sleep at home. We use it only to look after your health and to plan your training. The following roles can see it: [list]. The following cannot: the head coach in full detail, the general manager, and the commercial department. We will not use it in contract negotiations or in any arbitration. We keep it for [period] and delete it [period] after you leave. You can ask for a copy of your own data at any time and we will provide it within [10] days in a usable format. You can decline to wear any device, and declining will not affect selection, minutes, or any other decision about you. You can withdraw at any time, and if you do we will stop collecting, delete what we hold, and [state what happens to models]. Version [X], dated [date]. Please keep a copy.

Vendor data grant. Club grants Vendor a non-exclusive licence to use Athlete Data solely to provide, support, and maintain the Services for Club. Vendor shall not use Athlete Data to develop, train, or improve any product or model, to create benchmarking or industry outputs, or for research, except as expressly permitted at clause [X]. Vendor acknowledges that Club's rights in Athlete Data are limited by the Collective Bargaining Agreement and that Club does not purport to grant any right it does not hold. Vendor shall not disclose Athlete Data to any third party other than an approved subprocessor listed at Schedule [A].

Benchmarking permission. Vendor may include Athlete Data in Aggregated Outputs provided that each output: incorporates data from no fewer than [N] clubs and [M] athletes; contains no metric attributable to any individual athlete or to any single club; is produced by the documented methodology at Schedule [B], which Vendor shall not amend without Club's consent; and is provided to Club at the same time as to any other recipient. Vendor shall notify Club not less than [30] days before publishing any benchmarking study and shall provide the draft. Club may audit Vendor's aggregation practice annually on [notice].

Medical boundary protocol. The Clinical Record is held by the Medical Department and is accessible only to treating clinicians and the Athlete. The Performance Record is held separately and contains no clinical content. The only information passing from the Clinical Record to Performance or Coaching staff is the Athlete's availability status, expressed as [available / restricted, with permitted activities / unavailable], together with any expected return date. Diagnosis, test results, treatment, and prognosis do not cross. The treating clinician determines availability status and records the basis in the Clinical Record. No other person may request clinical detail, and any such request shall be logged and refused.

Genetic information prohibition. The Club shall not request, require, purchase, or accept genetic information relating to any Athlete or any family member of an Athlete, including family medical history, and shall not use any such information in any decision. Where an Athlete volunteers genetic information, it shall be recorded only in the Clinical Record and shall not be disclosed to any person outside the Medical Department. No vendor product incorporating genetic markers shall be procured or deployed. Any breach of this clause shall be reported immediately to the General Counsel.

Recorded class and synthesis. Athlete grants Club the right to record, reproduce, distribute, publicly perform, and make available recordings of Athlete's participation, and to use Athlete's name, image, and likeness in connection with them, worldwide, for [term], subject to the compensation at Schedule [C]. Nothing in this clause permits Club or any third party to create a digital replica of Athlete, to generate any new performance by synthetic means, or to synthesise Athlete's voice, without Athlete's separate written consent, which may be given or withheld for each proposed use. This restriction survives termination and continues after Athlete's death, when the consent of Athlete's estate is required.

Worked scenarios

The vendor conflict. A performance director signs a three-year analytics contract granting the vendor a perpetual licence for product development, benchmarking, and research. The collective agreement limits use to health and performance purposes. Legal never saw the contract. The conflict surfaces when the vendor publishes league-wide benchmarks and the union asks how they were compiled. Remediation: a renegotiated grant limited to aggregate metrics above a cohort threshold with no single-club attribution, deletion of the historic contribution, an audit right, and an internal rule routing every technology contract through legal. The union accepts it; a grievance with a public record would have cost more.

The stadium turnstile. A club installs facial recognition for expedited entry with a notice in the ticket terms and a checkbox at purchase. The state statute requires a written release and a published retention schedule before collection. Neither exists in the required form. Exposure is statutory damages per person scanned across tens of thousands of attendees. A compliant consent flow, a published schedule, matching vendor obligations, and a non-biometric lane were all available before launch at a fraction of the cost.

The vendor that narrowed its grant. A sports technology vendor's standard terms claim everything, and its three largest prospects all refuse. The counter-intuitive advice is to narrow: a defined aggregation right above a cohort threshold, with published methodology and an audit right, is more saleable than a broad grant every sophisticated buyer's counsel will strike — and it gives the vendor a selling point its competitors cannot match, namely that its terms are compatible with the customer's collective obligations.

The library with no rights. A platform is acquired and diligence finds that a third of the on-demand catalogue features athletes whose agreements predate the recording programme and contain no grant of recording, likeness, or distribution rights. Several have left on bad terms. The catalogue cannot be cleared quickly and the price reflects it.

Failures that recur

A technology contract signed without legal review, granting rights the club could not lawfully give.

Access lists wider in the system than on paper, with employment decision-makers able to see physiological data.

Medical and performance records in one system.

Consent obtained once at signing and never refreshed for technology introduced later.

Home collection treated identically to training-ground collection.

Biometric deployment at the venue with no written release — the largest single financial exposure in the sector.

Genetic information reaching a decision-maker through a volunteered consumer test or a clinician's finding.

Vendor de-identification accepted at face value across a population of a few hundred professionals.

No exit terms, discovered at supplier change.

Prop market supply agreed without checking the collective agreement.

A likeness grant read to permit synthesis, litigated a decade after drafting.

Youth data retained on the professional schedule.

And officials, staff, and trial participants measured under no framework at all.

Incident response and governance

Build the notification matrix before an incident: state breach statutes, contractual clocks, the collective agreement obligation, insurers, regulators, and any international regime, each with its threshold and clock, and identify who decides that a threshold is met. Treat the union as an immediate stakeholder rather than a party to be informed later. Engage counsel early enough for privilege to attach, retain forensic capability in advance, and rehearse once with the people who would run it. See Running a Data Breach Response.

During an incident, preserve before remediating, determine which categories were affected since medical and biometric categories change the obligations, determine whether minors or international athletes are involved, notify on the shortest applicable clock, and prepare for a reputational dimension that will dominate.

Ongoing governance. Name an owner with authority to stop a deployment; put legal in the technology procurement path without exception; review access lists quarterly against actual system permissions; review vendor grants annually against the current collective agreement; review the device list against what is actually deployed; train performance and medical staff annually in person; consult the union before deploying rather than explaining afterwards; and ask the athletes once a year what they object to, without their agents in the room.

And report to the board, because this is a business holding the physiological records of its own employees and its principal risk is the loss of their trust.

Sector variations

Team sports with strong unions. The collective agreement dominates and the work is compliance with it. Expect detailed device approval, access restriction, and commercialisation provisions, expect the joint committee to be the real forum, and consult before deploying rather than explaining afterwards.

Individual sports. No collective agreement, so the athlete's rights are whatever their contracts and the event regulations provide. Sponsors, equipment suppliers, national bodies, and international federations all assert overlapping data rights, and an adviser should map who has claimed what before negotiating anything.

Motorsport. Telemetry is the sport, the volumes are enormous, and the technical regulations themselves control what may be collected and transmitted. Inter-team confidentiality is intense and the trade secret analysis carries most of the weight.

Cycling and endurance. Athletes publish power and physiological data voluntarily on consumer platforms, which complicates any claim that the same data is confidential in a team's hands, and the athlete agreement should address the tension rather than ignore it.

Combat sports. Weight management and medical clearance data is safety-critical and supervised by athletic commissions, adding a public regulator to the analysis.

Esports. Player biometrics, gameplay telemetry, and streaming data combine with publisher licence terms controlling everything downstream.

Consumer fitness. The same sensors sold to the public under terms of service rather than collective agreements, with data that is frequently more intimate and protections that are weaker.

And officiating. Match officials are instrumented alongside players under no agreement that mentions them, and the first question is which contract or appointment terms apply.

The consent problem, stated honestly

Every framework in this area rests on consent, and consent here is a weaker foundation than the documents suggest.

The power asymmetry is extreme. An athlete on a one-year contract, competing for a place, asked to wear a device everybody else wears, is not making a free choice in any meaningful sense. Anti-retaliation language helps and does not solve it, because the decisions that matter — selection, minutes, renewal — are discretionary and unexplained.

Collective bargaining is the honest answer, and it is why the protections that exist are collectively negotiated rather than individually consented. A union can refuse what an individual cannot, and the resulting terms bind regardless of any individual's willingness to sign something worse.

Which explains the gap below the professional level, where individual consent is sought in circumstances that make it close to meaningless and the resulting arrangement is nonetheless enforceable.

The vendor consent layer is weaker still. An athlete consents to their club collecting data; the club contracts with a vendor whose terms permit aggregate use; and the athlete has consented to neither the vendor relationship nor the aggregation.

Withdrawal is the test. A consent that cannot practically be withdrawn is not a consent. Ask of any arrangement: what happens if this athlete says no tomorrow?

And the honest advice to a club is that consent is necessary and insufficient. The defensible position rests on collective agreement compliance, purpose limitation enforced by technical access controls, retention that expires, and a genuine separation between the people who measure and the people who decide.

The betting layer

Sports betting has become the largest commercial driver of athlete and event data, and it changes the incentives around every rule above.

In-play markets require low-latency official data, which makes the official feed genuinely valuable rather than merely convenient.

Official data mandates create a legal moat where a jurisdiction requires licensed operators to use league-supplied data for specified bet types — the single most consequential regulatory feature of the sports data business.

Integrity monitoring runs on the same infrastructure, matching unusual betting patterns against event data, which requires the operator, the league, and the regulator to share information about individual participants.

Player prop markets raise the sharpest question, monetising an individual athlete using data generated by their body, with consent frequently assumed rather than obtained.

Tracking-derived markets are the frontier, and settling a market on speed or biomechanical measures would depend directly on wearable data that collective agreements restrict to health and performance purposes. The tension between that restriction and the commercial opportunity is the negotiation to watch.

Athlete harassment is a real consequence, and leagues have begun treating abuse directed at athletes whose performance settles a market as a welfare issue with a data dimension.

And the regulatory layer is state by state, with licensing, advertising restrictions, and responsible gambling obligations that a data supplier inherits by contract even where it is not itself licensed.

Cross-border sport

Athletes move between jurisdictions mid-career, arriving with a longitudinal record created under a framework granting access, erasure, and portability rights the destination does not.

Competitions are held abroad, generating data on athletes from many nations, collected by an event organiser, processed by a technology partner, and distributed to broadcasters and betting operators worldwide.

Anti-doping adds its own regime, with whereabouts obligations, sample data, and therapeutic use exemptions flowing between the testing authority, the international federation, the national body, and the event organiser — a transfer structure with real complexity and genuinely sensitive content.

International federations impose rules binding national bodies and clubs by participation rather than by contract with the athlete, and those rules may conflict with local data protection requirements.

The transfer mechanism question is frequently unanswered. Clubs and leagues that would never move customer data across a border without a mechanism routinely move athlete physiological data between continents on the strength of nothing.

And the practical advice is unglamorous: map the flows including the international ones, identify the lawful basis and transfer mechanism for each, and be honest that the athlete's rights differ depending on where they happen to be playing.

The three-day test

The quickest diagnostic takes three days. Choose one deployed technology and ask for six documents: the joint committee approval for the device; the athlete consent in the version actually signed; the data grant in the vendor contract; the collective agreement provision that permitted that grant; the access list as configured in the system rather than as written in the policy; and the deletion certification for the last athlete who departed.

A programme producing all six will survive a grievance. One producing three is the ordinary case with a year of work ahead. One producing one has a policy rather than a practice, and the gap will surface in a grievance, a class action over a turnstile, or a diligence report.

One paragraph to remember

Athlete data is governed by the collective agreement first and by privacy statute second; biometric statutes bite hardest at the stadium gate, where the exposure is measured by attendance; genetic screening is prohibited rather than merely risky; competition data is protected by venue access and contract rather than by any property right; and the vendor's standard data grant is the most likely single source of a breach of obligations the club intended to honour. Separate the clinical record from the performance record technically, keep both away from the people who decide contracts, bound benchmarking by cohort size and published methodology, address synthesis expressly in every new agreement, treat minors more strictly than professionals, and test every proposal against whether it would survive being described plainly to the athlete it measures.

What the sensors actually measure

Being concrete about the instrumentation helps, because the legal analysis differs sharply between categories practitioners tend to lump together.

Positional tracking. Optical camera systems or radio tags producing coordinates at high frequency, from which distance, top speed, sprint counts, accelerations, and heat maps are derived. Behavioural and performance data, not obviously biometric in the statutory sense, and the category most freely commercialised.

Inertial measurement. Accelerometers and gyroscopes measuring impact, jump height, change of direction, and mechanical load — performance data with an injury-risk overlay that shades toward health information.

Cardiac monitoring. Heart rate, variability, and recovery indices: physiological and, depending on context, health information, and predictive of conditions the athlete may not know about, which is where the employment law constraints engage.

Sleep and recovery. Collected at home, overnight, and therefore the most intrusive category by location and the least connected to the workplace.

Metabolic and biochemical. Blood markers, saliva testing, sweat analysis, continuous glucose monitoring — clinical in character and squarely medical information whatever the club calls it.

Neurocognitive. Baseline and post-impact assessment, particularly in contact sports: genuinely clinical, with an unarguable safety justification and extreme data sensitivity.

Identification. Facial recognition or fingerprint access at facilities and stadiums — the category most likely to fall within a biometric statute and most likely to produce class litigation, frequently involving spectators.

And video, from which almost all of the above can be derived by computer vision without any wearable at all, which is the direction the technology is moving and which will make the device-based consent architecture progressively less relevant.

A closing observation

There is a version of this toolkit that treats athlete data as a compliance topic — statutes to satisfy, consents to obtain, retention schedules to publish. That version is accurate and misses the shape of the thing.

The shape is this. An employer has acquired the ability to measure an employee's body continuously, at a resolution that reveals conditions the employee does not know they have, in a market where the employer's decisions about that employee are worth tens of millions and are made without explanation. No general body of law was designed for that. What protects the athlete is a collective agreement, which exists because a union bargained for it, which is possible because the athletes concerned have leverage almost no other measured workforce possesses.

The technology will keep improving. Computer vision will make the wearable optional, which will make the device-based consent architecture obsolete. The data will get more revealing and the commercial demand will get larger. The protections will remain a function of bargaining power, which means the least protected people in the sector will continue to be the youngest.

A practitioner who understands that is positioned to give advice that is both accurate and useful. One who treats it as a checklist exercise will draft documents that comply and arrangements that do not hold.

Documents that must exist

For each item: does it exist, who owns it, and can it be produced within three working days?

The collective agreement and its data provision summary.
The joint committee's approved device list, current.
The data inventory with a basis recorded per stream.
Access lists as configured, with the date of the last audit.
The medical boundary protocol, signed by the clinicians.
The genetic firewall policy and its leak-route assessment.
Biometric written releases by collection point, and the published retention schedule.
Athlete consent forms, versioned and dated, with distribution records.
Separate home-collection consents.
Every technology and analytics contract with the data grant flagged, and the comparison against the collective agreement.
Benchmarking methodology documents and audit records.
Model ownership and termination terms.
Exit terms with export format and deletion certification.
Official data supply agreements with latency, audit, and scope terms.
The prop and tracking-derived market consent basis.
Likeness clearance files per commercial use, and the synthesis clauses in current agreements.
Athlete access request log and response times, portability exports, and deletion certifications on departure.
Parental consents and minor retention schedules.
Cross-border transfer mechanisms per flow, and the anti-doping data flow map.
The breach notification matrix and the rehearsal record.
Union consultation records for each deployment.

Key Authorities at a Glance

Employment and bargaining. 29 U.S.C. § 158 makes monitoring a mandatory bargaining subject. 42 U.S.C. § 12112 constrains medical examinations and requires separate confidential records. 42 U.S.C. § 2000ff prohibits requesting, requiring, or purchasing genetic information including family medical history.

Privacy and biometrics. State biometric statutes require written notice and release before collection, impose retention limits, prohibit sale, and provide a private right of action, with standing analysed in Rosenbach v. Six Flags Entertainment Corp.. The medical privacy rule sits at 45 C.F.R. § 164 where a covered relationship exists. Deceptive practices enforcement runs under 15 U.S.C. § 45.

Data and competition. Feist Publications, Inc. v. Rural Telephone Service Co.; National Basketball Ass'n v. Motorola, Inc.; 18 U.S.C. § 1030 with Van Buren v. United States and hiQ Labs, Inc. v. LinkedIn Corp.; 17 U.S.C. § 102 and 17 U.S.C. § 106 for broadcast.

Publicity and likeness. Zacchini v. Scripps-Howard Broadcasting Co.; Keller v. Electronic Arts Inc.; Hart v. Electronic Arts, Inc.; 15 U.S.C. § 1125.

Trade secret. 18 U.S.C. § 1836 with Rockwell Graphic Systems, Inc. v. DEV Industries, Inc..

| Authority | Governs | Practical consequence | | --- | --- | --- | | 29 U.S.C. § 158 | Mandatory bargaining | The collective agreement governs | | 42 U.S.C. § 2000ff | Genetic information | Screening is prohibited outright | | 42 U.S.C. § 12112 | Medical inquiries | Separate confidential records required | | State biometric statutes | Identifiers | Written release before collection | | Rosenbach | Standing | Technical violation suffices | | Feist | Facts | No property in the score | | NBA v. Motorola | Real-time data | Narrow hot news survival | | Keller; Hart | Likeness in games | Realistic depiction needs clearance | | Zacchini | Performance | The whole act doctrine | | Van Buren | Computer access | Limits on scraping claims | | 18 U.S.C. § 1836 | Trade secrets | Where analytics value is protected | | 45 C.F.R. § 164 | Health privacy | Applies only where covered |